A single dose of psilocybin coupled with “talk therapy” can significantly reduce depression in people with cancer for up to two years, according to a new study. While the study has limitations, its ...

In 1984, my grandfather took his last breath and shuffled off this mortal coil after a nasty bout with cancer. I was only 13 at the time, and probably didn’t fully understand the pain he was in. Not ...

A popular modern trend involves taking tiny amounts of psychedelic mushrooms to boost brain power, but new evidence suggests the benefits may be largely imaginary. A rigorous scientific investigation ...

New results from a clinical trial reveal that a single dose of psilocybin-a naturally occurring psychedelic compound found in mushrooms-can provide sustained reductions in depression and anxiety in ...

‘Magic mushrooms’ can provide effective treatment for depression after one or two doses, a new study has found. A single dose of Psilcybin, which is the active ingredient in magic mushrooms, has been ...

Researchers have developed a new model to study the antidepressant and anti-anxiety effects of psilocybin in mice.

A single dose of psilocybin combined with psychological support can provide lasting relief from depression and anxiety in patients with cancer. In a phase 2 clinical trial, more than half of patients ...

Please provide your email address to receive an email when new articles are posted on . Patients treated with high-dose psilocybin had better responses compared with placebo in antidepressant trials.

A new study published in Progress in Neuropsychopharmacology & Biological Psychiatry has found that a single moderate dose of psilocybin produces rapid and lasting antidepressant-like effects in rats, ...

Research has already shown the psychedelic drug psilocybin eases depression, PTSD, and anxiety. Now researchers are working ...

Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to ...

Entropy Neurodynamics has received positive Phase 2a results for its psilocybin-based therapy in patients with Binge Eating ...